Jim Simons Nex Immune, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.2 - $0.3 $1,780 - $2,670	8,900 Added 15.72%	65,500 $14,000
Q2 2023 Aug 11, 2023	BUY	$0.26 - $0.47 $4,472 - $8,083	17,200 Added 43.65%	56,600 $16,000
Q1 2023 May 12, 2023	SELL	$0.3 - $0.6 $75,090 - $150,180	-250,300 Reduced 86.4%	39,400 $15,000
Q4 2022 Feb 13, 2023	BUY	$0.21 - $18.5 $58,170 - $5.12 Million	277,000 Added 2181.1%	289,700 $70,000
Q3 2022 Nov 14, 2022	BUY	$0.6 - $17.5 $7,620 - $222,250	12,700 New	12,700 $7,000
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $118,594 - $344,733	-73,661 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.79 - $4.65 $40,742 - $105,838	22,761 Added 44.72%	73,661 $310,000
Q4 2021 Feb 11, 2022	BUY	$4.11 - $15.13 $209,199 - $770,117	50,900 New	50,900 $235,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.